
ASHPOfficial is the premier podcast of ASHP and the collective voice of our 50,000 members in health-system pharmacy. Through interviews and discussions with pharmacy thought leaders, ASHPOfficial will explore issues related to public health, medication use, and supporting the professional practice of pharmacists in hospitals, health systems, ambulatory clinics, and other settings. To learn more about ASHP, please visit ashp.org.
Episodes

Wednesday May 19, 2021
Evaluation of Burnout Among Pharmacy Residents in the United States
Wednesday May 19, 2021
Wednesday May 19, 2021
Join us for a conversation with the research grant teams from the ASHP Foundation New Practitioner Pharmacists Leadership Grant. Their topic of research is Evaluation of Burnout Among Pharmacy Residents in the United States. Learn about burnout versus exhaustion, and what the researchers uncovered in their study of residents across the United States.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Wednesday May 19, 2021
Leadership in Ambulatory Care Pharmacy Practice: Looking Back and Looking Ahead
Wednesday May 19, 2021
Wednesday May 19, 2021
Careers in ambulatory care pharmacy practice have shifted from solely focusing on direct patient care to management of interprofessional teams, advocacy, and educating learners. In this Practice Journeys episode, we hear from Danny Fu – Manager, Ambulatory Care Pharmacy at Atrium Health and learn more about his career path, involvement with ASHP, and vision for the future of ambulatory care pharmacy practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Tuesday May 18, 2021
COVID-19 Vaccine EUA Updates
Tuesday May 18, 2021
Tuesday May 18, 2021
The focus on this podcast will be on providing updates on the available COVID-19 Vaccines with EUA, with particular emphasis on the most recent one to be approved: Johnson & Johnson’s Janssen vaccine. This podcast will cover information related to storage requirements, preparation and administration instructions, and efficacy and safety data. This podcast will compare and contrast the three available vaccines (Pfizer, Moderna, and J&J) to summarize their similarities and differences. Finally, this podcast will include brief information regarding anticipated EUA updates such as new age approvals for the Pfizer vaccine.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Monday May 17, 2021
Importance of Emotional Intelligence in Pharmacy Leadership
Monday May 17, 2021
Monday May 17, 2021
This podcast will cover basic definitions of emotional intelligence and its importance in a role of pharmacy leadership. The speakers will reflect on their own experiences building emotional intelligence while developing relationships with colleagues as new practitioners and how it helps augment successful crucial conversations. Lastly, the speakers will provide practical advice and resources for new practitioners to learn more about this topic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Friday May 14, 2021
COVID-19: Set the Stage to Engage Your Specialty Pharmacy Team
Friday May 14, 2021
Friday May 14, 2021
Through a series of podcasts, members of the Section of Specialty Pharmacy Practitioners discuss the state of specialty pharmacy during the COVID-19 pandemic and how practice continues to adapt and evolve. During this podcast, speakers highlight strategies to engage team members and assess employee satisfaction and wellness as new staffing models emerge.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Thursday May 13, 2021
Rural Primary Care Approach to Managing Medication Costs
Thursday May 13, 2021
Thursday May 13, 2021
While COVID-19 has impacted patient insurance statuses and ability to pay for high-cost medications, rural patients have encountered this barrier for years. During this podcast a primary care physician and clinical pharmacist will discuss the impact of patient assistance programs in allowing all patients access to guideline recommended therapies, as well as how to implement this service into your practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Thursday May 13, 2021
Thursday May 13, 2021
This podcast explores the reintroduction of provider status legislation by Congress. Tom Kraus and Doug Huynh discuss what the bill does, how it will impact pharmacy, what is the path forward, and what ASHP members can do to advance the legislation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Wednesday May 12, 2021
ASHP Advantage: VTE Prophylaxis in the Medically Ill: Extending the Conversation, Part 3
Wednesday May 12, 2021
Wednesday May 12, 2021
Pharmacists have a role in managing anticoagulant therapy in acutely ill hospitalized patients at risk for VTE, including protocol development and research, identifying unmet need and the value of prophylaxis in medically ill patients, and implementing practical DVT and PE prevention strategies. Consensus guidelines (e.g., COVID-19 ISTH 2020, COVID-19 ACC) have provided some guidance for COVID-19 infection and the connection to deep vein thrombosis and pulmonary embolism.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Tuesday May 11, 2021
Tuesday May 11, 2021
In Part Two of this podcast, straight from the 2020 Midyear Clinical Meeting, Dr. Igneri describes the clinical manifestations of COVID-19 associated coagulopathy, shares best practices on interpreting the available literature and given a patient scenario, design a treatment plan to manage COVID-19 associated coagulopathy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Monday May 10, 2021
Hyperosmolar Therapy in the Critically Ill
Monday May 10, 2021
Monday May 10, 2021
Acute elevations in intracranial pressure from brain injury or illness can be life-threatening or lead to significant morbidity. Rapid identification and lowering of the intracranial pressure with directed therapy in the form of hyperosmolar therapy while awaiting definitive management of the underlying cause is essential in many cases. This podcast will discuss the selection between mannitol and hypertonic saline, logistics of storage and administration in the emergency department, goals of therapy, and monitoring parameters.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
